Ken Yamashita1, Shiro Oka2, Shinji Tanaka3, Shinji Nagata4, Yuko Hiraga5, Toshio Kuwai6, Akira Furudoi7, Tadamasa Tamura8, Masaki Kunihiro9, Hideharu Okanobu10, Koichi Nakadoi11, Hiroyuki Kanao12, Makoto Higashiyama13, Kazuya Kuraoka14, Fumio Shimamoto15, Kazuaki Chayama1. 1. Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. 2. Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. oka4683@hiroshima-u.ac.jp. 3. Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan. 4. Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan. 5. Department of Endoscopy, Hiroshima Prefectural Hospital, Hiroshima, Japan. 6. Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan. 7. Department of Gastroenterology, JA Hiroshima General Hospital, Hiroshima, Japan. 8. Department of Internal Medicine, Hiroshima Memorial Hospital, Hiroshima, Japan. 9. Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan. 10. Department of Gastroenterology, Chugoku Rosai Hospital, Kure, Japan. 11. Department of Gastroenterology, JA Onomichi General Hospital, Onomichi, Japan. 12. Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan. 13. Department of Gastroenterology, Shobara Red Cross Hospital, Shobara, Japan. 14. Department of Anatomical Pathology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan. 15. Faculty of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan.
Abstract
BACKGROUND: We analyzed the influence of preceding endoscopic submucosal dissection (ESD) on the prognosis of patients with T1 colorectal carcinoma (CRC) after additional surgery using propensity-score matching. METHODS: 1638 consecutive patients with T1 CRC were retrospectively identified between January 1998 and December 2016 at the Hiroshima GI Endoscopy Research Group. We assessed 602 patients with 602 T1 CRC who underwent additional surgery after ESD (n = 216) or surgery alone (n = 386). The enrolled patients were treated according to the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016, and were defined as non-endoscopically curable (non-e-curable) when they did not satisfy its curative criteria. We analyzed the pathological characteristics and the prognosis of non-e-curable patients using propensity-score matching between the additional surgery after ESD and surgery alone groups. RESULTS: There were no cases of recurrence and lymph node metastasis among the e-curable patients. The rate of lymph node metastasis and recurrences in the non-e-curable patients were 10.8% and 2.6%, respectively. After propensity-score matching, there were no significant differences in the 5-year overall survival rates (96.9% vs. 92.0%), 5-year disease-free survival rates (96.7% vs. 96.7%) and 5-year disease-specific survival rates (100% vs. 98.6%) after treatment of T1 CRCs between the 2 groups in non-e-curable patients. CONCLUSIONS: Preceding ESD with histological en bloc resection for patients with T1 CRC did not affect their oncologic behavior adversely after additional surgery.
BACKGROUND: We analyzed the influence of preceding endoscopic submucosal dissection (ESD) on the prognosis of patients with T1 colorectal carcinoma (CRC) after additional surgery using propensity-score matching. METHODS: 1638 consecutive patients with T1 CRC were retrospectively identified between January 1998 and December 2016 at the Hiroshima GI Endoscopy Research Group. We assessed 602 patients with 602 T1 CRC who underwent additional surgery after ESD (n = 216) or surgery alone (n = 386). The enrolled patients were treated according to the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016, and were defined as non-endoscopically curable (non-e-curable) when they did not satisfy its curative criteria. We analyzed the pathological characteristics and the prognosis of non-e-curable patients using propensity-score matching between the additional surgery after ESD and surgery alone groups. RESULTS: There were no cases of recurrence and lymph node metastasis among the e-curable patients. The rate of lymph node metastasis and recurrences in the non-e-curable patients were 10.8% and 2.6%, respectively. After propensity-score matching, there were no significant differences in the 5-year overall survival rates (96.9% vs. 92.0%), 5-year disease-free survival rates (96.7% vs. 96.7%) and 5-year disease-specific survival rates (100% vs. 98.6%) after treatment of T1 CRCs between the 2 groups in non-e-curable patients. CONCLUSIONS: Preceding ESD with histological en bloc resection for patients with T1 CRC did not affect their oncologic behavior adversely after additional surgery.
Authors: J Ferlay; M Colombet; I Soerjomataram; T Dyba; G Randi; M Bettio; A Gavin; O Visser; F Bray Journal: Eur J Cancer Date: 2018-08-09 Impact factor: 9.162
Authors: Liang Wenquan; Liu Yuhua; Cui Jianxin; Xi Hongqing; Zhang Kecheng; Li Jiyang; Gao Yunhe; Liu Yi; Zhang Wang; Li Shaoqing; Lu Yixun; Qiao Shen; Xue Wanguo; Qiao Zhi; Chen Lin Journal: Cancer Med Date: 2020-03-12 Impact factor: 4.452